| Yongxin Chen, MD | |
|
8000 Wolf River Blvd., Ste. 200, Germantown, TN 38138 | |
| (901) 747-3630 | |
| Not Available |
| Full Name | Yongxin Chen |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 8000 Wolf River Blvd., Germantown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528354883 | NPI | - | NPPES |
| 513603YMVL | Other | MS | MEDICARE PTAN |
| 103I223891 | Other | TN | MEDICARE PTAN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marlboro Chesterfield Pathology, Pc | 4486546819 | 10 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Entity Name | Pinehurst Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255388369 PECOS PAC ID: 5991617169 Enrollment ID: O20031105000305 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Entity Name | Eagle Physicians And Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457436982 PECOS PAC ID: 0244134468 Enrollment ID: O20031120000436 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Entity Name | Coastal Carolina Health Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780623207 PECOS PAC ID: 9739087693 Enrollment ID: O20031230000224 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Entity Name | Wilmington Gastroenterology Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922040419 PECOS PAC ID: 2163315672 Enrollment ID: O20040206000443 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Entity Name | Marlboro Chesterfield Pathology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619953965 PECOS PAC ID: 4486546819 Enrollment ID: O20050929000695 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yongxin Chen, MD 2020 Exeter Rd, Germantown, TN 38138-3945 Ph: (901) 260-8379 | Yongxin Chen, MD 8000 Wolf River Blvd., Ste. 200, Germantown, TN 38138 Ph: (901) 747-3630 |
News Archive
ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
SURGEONS should be given regular ‘emotional intelligence' training as an ‘explicit' part of their professional development - to combat epidemic levels of burnout in the profession.
Omitting pelvic computed tomography scans from the routine surveillance of off-therapy patients with Wilms tumor could reduce radiation exposure without compromising relapse detection rates, researchers report.
Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.
› Verified 6 days ago